DelfaGLP-1 Atlas

Lead sponsor

Henrik Gudbergsen

9 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

9

Trials led

0

Active

1,480

Total enrollment

4

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 4
4
Not applicable
5

Trials by status

Completed
7
Unknown
2

Trials led

IM-LOSEIT-I—not applicableCompleted200
BIO-LOSEIT-I—not applicableUnknown200
US-LOSEIT-IBMI ≥27not applicableCompleted200
CIMT-LOSEIT-IBMI ≥27not applicableCompleted200
LOSEITBMI ≥27Ph 4Completed150
BIO-LOSEIT-II—Ph 4Completed150
IM-LOSEIT-II—Ph 4Completed150
US-LOSEIT-IIBMI ≥27Ph 4Completed150
Ultrasound Assessment of the Adventitia, Extra-media (EMT) and Veia Jugularis Interna ThicknessBMI ≥27not applicableUnknown80